Insider Transactions in Q1 2023 at Sonnet Bio Therapeutics Holdings, Inc. (SONN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Pankaj Mohan Chairman, President and CEO |
BUY
Open market or private purchase
|
Direct |
60,000
+24.82%
|
$0
$0.58 P/Share
|
|
Feb 06
2023
|
John Harry Cross Iii Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,960
-7.57%
|
$1,960
$1.06 P/Share
|
|
Feb 06
2023
|
Donald J. Griffith Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
497
-4.6%
|
$497
$1.04 P/Share
|
|
Jan 07
2023
|
Pankaj Mohan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
73,561
+37.67%
|
-
|
|
Jan 07
2023
|
Pankaj Mohan Chairman, President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
73,561
-60.43%
|
-
|
|
Jan 07
2023
|
John K. Cini Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,551
+31.54%
|
-
|
|
Jan 07
2023
|
John K. Cini Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,551
-46.07%
|
-
|
|
Jan 07
2023
|
Richard T Kenney Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,627
+44.56%
|
-
|
|
Jan 07
2023
|
Richard T Kenney Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,627
-80.38%
|
-
|
|
Jan 07
2023
|
Susan Dexter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,627
+38.2%
|
-
|
|
Jan 07
2023
|
Susan Dexter Chief Technical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,627
-61.8%
|
-
|